CompoAtlas

ČAGAS UZLĒJUMS ar vērmeli (Paziņots 2014.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000103/2014
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
SIPRO, SIA
Manufacturer
SIPRO, SIA
Origin
Latvija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
3 ēdamkarotes (45 ml)
Published pack size
200ml, 250ml, 500ml
Published packaging
200ml, 250ml, 500ml

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
Bērzu piepes augķermeņa uzlējumsplants ; Bērzu piepes augķermeņa uzlējums ; Inonotus obliquus ; 43.2 ; mlinonotus obliquusPlant
Vērmeļu lapu un stublāju uzlējumsplants ; Vērmeļu lapu un stublāju uzlējums ; Artemisia vulgaris ; 1.8 ; mlartemisia vulgarisPlant

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Latvija

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Vērmeļu lapu un stublāju uzlējums
    Read the warning, when it applies and the studies cited

    MUGWORT - ARTEMISIA VULGARIS

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Brinker 2010; Blumenthal et al. 1998; Williamson et al. 1988).

    Sources cited by Health Canada (3)
    • Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C, Rister R, editors. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin (TX): American Botanical Council; 1998.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Williamson EM, Evans FJ, Wren RC. Potter's New Cyclopaedia of Botanical Drugs and Preparations. Saffron Walden (UK): C.W. Daniel Company Limited; 1988.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010; Wichtl 2004; Hoffmann 2003).

    Sources cited by Health Canada (3)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
    • Wichtl M, editor. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis, 3rd edition. Stuttgart (D): Medpharm GmbH Scientific Publishers; 2004.

    Health Canada monograph dated 31 July 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “ČAGAS UZLĒJUMS ar vērmeli (Paziņots 2014.)”, https://compoatlas.com/en/supplements/latvia/4181-cagas-uzlejums-ar-vermeli-pazinots-2014, updated 28 October 2026.

Enter to analyse, Shift+Enter for a new line